120 related articles for article (PubMed ID: 545820)
1. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Soloway MS; Cox CE
Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
[TBL] [Abstract][Full Text] [Related]
2. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
3. A murine model for bladder cancer.
Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
Soloway MS
Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
[TBL] [Abstract][Full Text] [Related]
5. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
7. Chemoimmunotherapy of murine bladder cancer.
Stogdill BJ; Lamm DL; Livingston RB
Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
[TBL] [Abstract][Full Text] [Related]
8. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
[TBL] [Abstract][Full Text] [Related]
9. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
[TBL] [Abstract][Full Text] [Related]
10. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
Yamauchi T; Okada K; Yoshida O; Kawai T
Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
Sulkes A; Fuks Z
Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
[No Abstract] [Full Text] [Related]
12. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
Niell HB; Wood CA; Mickey DD; Soloway MS
Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of invasive bladder cancer].
Kotake T
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy of advanced bladder cancer].
Kiyohara H
Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
[TBL] [Abstract][Full Text] [Related]
15. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED
Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
18. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
[TBL] [Abstract][Full Text] [Related]
19. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
20. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
Yagoda A
Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]